1. Levi M, Keller TT, van Gorp E, ten Cate H. Infection and inflammation and the coagulation system. Cardiovasc Res. 2003; 60:26–39.
2. Dempfle CE. Coagulopathy of sepsis. Thromb Haemost. 2004; 91:213–24.
Article
3. Lee HS, Byun SH. Early diagnostic laboratory tests of disseminated intravascular coagulation in newborn infants. J Korean Soc Neonatal. 1999; 6:78–84.
4. Nah J, Park CJ, Chi HS. Quantitation of D-dimer, Thrombin-Anti-thrombin III complx and Prothrombin Fragment 1+2 in patients with disseminated intravascular coagulation and venous thrombosis. Korean J Clin Pathol. 1998; 18:35–41.
5. Robert SM. Severe Sepsis and Septic shock. Kasper DL, Braunwald E, editors. Harrison's principles of Internal Medicine. 16th ed.New York: McGraw-Hill Professional;2004. p. 1606–10.
6. Levi M, ten Cate H, van der Poll T. Endothelium: interface between coagulation and inflammation. Crit Care Med. 2002; 30:220–4.
Article
7. Roberts HR, Monroe DM, Escober MA. Current concepts of hemostasis: implications for therapy. Anesthesiology. 2004; 100:722–30.
8. Schleef RR, Bevilacqua MP, Sawdey M, Gimbrone MA Jr, Loskutoff DJ. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J Biol Chem. 1988; 263:5797–803.
Article
9. ten Cate H, Bauer KA, Levi M, Edgington TS, Sublett RD, Barzegar S, et al. The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor. J Clin Invest. 1993; 92:1207–12.
Article
10. ten Cate H. Pathophysiology of disseminated intravascular coagulation in sepsis. Crit Care Med. 2000; 28:9–11.
Article
11. Esmon CT, Fukudome K, Mather T, Bode W, Regan LM, Stearns-Kurosawa DJ, et al. Inflammation, sepsis, and coagulation. Haematologica. 1999; 84:254–9.